Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis

Oncologist - United States
doi 10.1634/theoncologist.2019-0661
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Analysis of Real World Data to Evaluate Survival Benefit of Radiation Therapy in Stage III / N2 Non-Small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Identifying Patterns of Care for Elderly Patients With Non-Surgically Treated Stage III Non-Small Cell Lung Cancer: An Analysis of the National Cancer Database

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

Neo-Adjuvant Chemo/Immunotherapy in the Treatment of Stage III (N2) Non-Small Cell Lung Cancer: A Phase I/Ii Pilot Study

International Journal of Immunopathology and Pharmacology
AllergyImmunologyPharmacology
2011English

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2017English

Tri-Modality Treatment in N2 Stage IIIa Non-Small Cell Lung Cancer: Proper Sequence Remains Unknown

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Better Overall Survival With Advanced Radiation Treatment Modalities in Stage II and III Non-Small Cell Lung Cancer (NSCLC): A National Cancer Data Base Analysis

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Optimal Managements of Stage IIIA (N2) Non-Small Cell Lung Cancer Patients: A Population-Based Survival Analysis

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Applicability of a Prognostic CT-based Radiomic Signature Model Trained on Stage I-Iii Non-Small Cell Lung Cancer in Stage IV Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy